跳至主要内容
临床试验/DRKS00026023
DRKS00026023已完成不适用

Description of (re-)induction therapies prior to a planned stem cell transplantation in patients with relapsed / refractory multiple myeloma in Germany

AMGEN (Europe) GmbH0 个研究点目标入组 187 人开始时间: 2021年9月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
187

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patient aged 18 years or older at index date*
  • - Patient with diagnosis of MM histologically or cytologically confirmed as defined according to IMWG
  • - Patient had already received at least one therapy for MM and then relapsed or was refractory to initial therapy after initial response
  • - Patient was planned to receive myeloablative conditioning and SCT in second or third line based on assessment at index date*
  • - Start date of (re-)induction therapy (index date*) was within the period from January 2016 to December 2019
  • - Patient had completed a (re-)induction therapy in second or third line (index therapy)
  • *Index date is defined as start of (re-)induction therapy for a planned myeloablative conditioning and SCT in second or third line.

排除标准

  • - Patient not eligible for SCT based on physician’s assessment prior to start of (re )induction therapy in second or third line.
  • - Patient did not complete (re-)induction therapy in second or third line.

研究者

相似试验

已完成
不适用
Randomised induction and post-induction therapy in adult patients (less than or equal to 60 years of age) with acute myelocytic leukaemia (AML) or refractory anaemia with excess of blasts (RAEB, RAEB-t) with IPSS score greater than or equal to 1.5Acute myeloid leukaemia (AML)Myeloid leukaemiaCancer
ISRCTN38648181Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)800
进行中(未招募)
不适用
Randomised induction and post induction therapy in older patients (>=61 years of age) with acute myeloid leukaemia (AML) and refractory anaemia with excess blasts (RAEB, RAEB-t) - HOVON 43Acute Myeloid Leukaemia (AML)Refractory Anaemia with Excesss Blasts (RAEB)
EUCTR2004-001918-13-GBniversity of Wales College of Medicine800
尚未招募
3 期
Effects of standard induction therapy vs. no induction in renal transplant recipients at low immunological risk of graft rejectio
CTRI/2024/01/061771Post Graduate Institute of Medical Education and Research, Chandigarh.
已完成
不适用
Early evaluation of therapy response (targeted therapy and immunotherapy) in patients with metastasized malignant melanoma by multiparametric PET/MR imaging.C43.9Malignant melanoma of skin, unspecified
DRKS00013925niversitätsklinikum Tübingen, Radiologische Klinik, Diagnostische & Interventionelle Radiologie62
尚未招募
不适用
A new protocol of early rehabilitation after unilateral primary total hip arthroplastyOsteoarthritis of hip joint
JPRN-UMIN000040825Department of Orthopaedic Surgery, Graduate School of Medicine Tohoku University30